Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses

Thanks for that info:

"The omission or misstatement of an item in a financial report is material if, in the light of surrounding circumstances, the magnitude of the item is such that it is probable that the judgment of a reasonable person relying upon the report would have been changed or influenced by the inclusion or correction of the item"

For me, the ommission of information about recurring revenues through ongoing royalty payment structures would have changed my judgement significantly. Other's may disagree, but I consider myself a reasonable person.

Share
New Message
Please login to post a reply